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the nature of adipocytes is the differentiation and subse-
quent lipid droplet accumulation in mesenchymal stromal 
cells (MSCs) and preadipocytes (3–5). Novel methods that 
are robust enough to detect early stages of differentiation 
would accelerate our understanding of metabolic diseases 
and other disorders involving lipid accumulation.
Various methods have been used to quantify adipogenesis 
in vitro (6–12). However, they all rely on liquid handling 
steps, including fixation, diverse staining, imaging, and im-
age analysis procedures, which all require lengthy process 
optimizations and are therefore difficult to reproduce 
quantitatively (13). Other methods rely on RNA quantifica-
tion or biochemical assays, but these fail to capture the 
morphological changes and single cell properties that 
define adipogenesis. One of the main challenges when as-
sessing adipocytic differentiation is the extreme fragility 
of mature adipocytes. Not only are adipocytes sensitive to 
temperature fluctuations or oxygenation, but they also 
have a natural tendency to detach and float, which in-
creases variation and quantification biases (14). In order to 
avoid procedural biases, it has become standard to detect 
and assess adipocyte differentiation at early stages by using 
rapidly differentiating clonal lines (6). This approach lim-
its our understanding of the mechanisms of adipocyte dif-
ferentiation to the existing lines and may fail replication in 
alternative lines. In addition, improving adipocyte differ-
entiation detection methods would be compatible with 
measurements at earlier time points. Here, we report a new 
method that enables detection of lipid droplets in differen-
tiating adipocytes, without the need for washing, staining, 
or other liquid manipulations. Digital holographic micros-
copy (DHM) allows for the reconstruction of images based 
on the ability of tissue to refract light (15, 16). While the 
sample is illuminated with a laser emitting a specific wave, 
a reference beam passes in parallel to the sample, and the 
combination of both waves creates a hologram encoding 
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phase shift information (17). Quantitative phase images 
are then numerically reconstructed from the hologram, 
which contains morphological and intracellular informa-
tion related to the refractive index of the monitored cells. 
Lipid droplets have a higher refractive index, producing a 
very strong contrast, and are thus easily quantified. The 
ability to numerically “refocus” the image postacquisition 
allows for rapid and noninvasive sampling (18). In this 
study, we used the bone marrow-derived MSC line OP9 
(19), as it is both described as a model of rapid adipocytic 
differentiation and it was derived nonclonally, allowing us 
to assess the heterogeneity of cells undergoing adipocytic 
differentiation (20, 21). We compared the ability of DHM 
to capture adipocytic differentiation with other existing 
quantification methods, including flow cytometry (22) and 
fluorescence imaging. We performed a time-lapse analysis 
of OP9 adipocytic differentiation and tested the capacity of 
DHM to capture modulations of adipocytic differentiation 
using different enhancers and inhibitors added in a dose-
responsive manner. Additionally, we showed how the opti-
cal phase shift could be used to quantify other morphological 
changes, including cell confluence and cell death. Taken 
together, these results point to DHM as being a rapid, 
robust, marker-free, and nonperturbing method, suitable 
for medium- to high-throughput screenings of adipocytic 
differentiation.
MATERIALS AND METHODS
Cell culture and adipocytic differentiation
OP9 cells (provided by T. Nakano, Kyoto University, Japan) 
were maintained in Minimum Essential Media  with GlutaMaxTM 
(Gibco, catalog no. 32561), 10% FBS (Gibco, catalog no. 10101), 
and penicillin/streptomycin (Gibco, catalog no. 15140) at 37°C 
and 5% CO2. The cells were split when subconfluent every 3–4 
days. For every experiment, the cells were plated at confluence, 
i.e., 20.000 cells per cm2 (unless otherwise specified). Microscopy 
experiments were performed in 384-well plates, for which we 
plated 2,000 cells per well in a volume of 30 µl using an automatic 
liquid dispenser. Tested compounds were plated before the cells 
using the ECHO500 acoustic dispenser (Labcyte). Adipocytic dif-
ferentiation was performed during 6 days using a differentiation 
cocktail containing dexamethasone (Sigma, catalog no. D4902; 
10 µM), insulin (Sigma, catalog no. I0516; 5 g/ml), and isobutyl-
methylxanthine (I5879, 0.5 mM). The differentiation cocktail was 
added at double concentration in 30 µl of medium immediately 
after the cells were plated, making a final volume of 60 µl per well. 
For toxicity assessment, cells were incubated with gambogic acid, 
colchicine, taxol, and staurosporine in concentrations ranging 
from 1 nM to 30 M.
Microscopy
DHM technology and image reconstruction are described in 
detail elsewhere (15, 18, 23). DHM is a label-free interferometric 
microscopy technique, which provides a quantitative measure-
ment of the optical path difference (OPD; related to the optical 
density of the cell). It is a two-step process where a hologram con-
sisting of a 2D interference pattern is first recorded on a digital 
camera (Fig. 1A), and the quantitative phase images are then 
numerically reconstructed using a specific algorithm (Fig. 1B). 
The phase contrast in DHM images is quantitatively related to the 
OPD (Fig. 1C), expressed in terms of physical properties as:
( ) ( ) ( )– ,c mOPD x,y = d x,y  n x,y n    (Eq. 1)
where d(x,y) is the cell thickness, nc(x,y) is the mean z-integrated 
intracellular refractive index at the (x,y) position, and nm is the 
refractive index of the surrounding culture medium. Simply, 
equation 1 means that the OPD signal is proportional to both the 
cell thickness (providing information about cell morphology) 
and the intracellular refractive index (providing information 
about the intracellular content of the cells, mostly protein and 
lipid content).
DHM systems generally use a low-intensity laser as light source 
for specimen illumination. Here, the 684 nm laser source delivers 
roughly 200 W/cm2 at the specimen plane, approximately six 
orders of magnitude less than intensities typically associated with 
confocal fluorescence microscopy. With that amount of light, the 
exposure time is only 400 s. An extensive quality control of DHM 
can be found in Rappaz et al. (24).
Digital holographic imaging was performed in black wall 384-
well imaging plates (Corning, catalog no. 353962) using Trans-
mission DHM® T1000 (Lyncée Tec, Switzerland). Plates were 
precoated with poly-ornithine (Sigma, catalog no. P3655; 100 
mg/l) to prevent cell detachment. The cells were imaged live and 
without prior liquid manipulation using both a 10×/0.3 numeri-
cal aperture (NA) and 20×/0.4 NA microscope objectives. By tak-
ing four images per well, we covered almost one-fifth of the well 
surface (using the 10× objective). The best-focus phase images 
were reconstructed automatically in MATLAB (MathWorks) from 
the acquired holograms, and the average quantitative phase sig-
nal or OPD (16) was automatically measured using a fixed thresh-
old value.
Fluorescence Images were taken with the InCell Analyzer 2200 
(GE Healthcare) Imaging system. The neutral lipid droplets were 
stained with either LipidTox Deep Red (Life Technologies, cata-
log no. 34477) at 1:500 or Nile Red (Sigma, catalog no. N3013) at 
10 M. The nuclei were stained with Hoechst 33342 (1 µg/ml; 
ThermoFisher). For LipidTox imaging, the dyes were directly 
added to the wells, whereas for Nile Red imaging, the dyes were 
added with new medium. The wells were washed once with me-
dium after 30 min, as recommended by the manufacturer. For 
toxicity assessment, dead cells were stained using ethidium- 
homodimer (Et-HD; Invitrogen, catalog no. E1169), and all cells 
were stained with Hoechst (catalog no. 33342, ThermoFisher), by 
directly adding the dyes into each well and imaging without any 
washing steps after 30 min incubation. As was done with DHM, 
four pictures were taken per well. Digital phase contrast images 
were additionally taken with the InCell Analyzer 2200.
Image processing
For digital holographic imaging, the cells were first automati-
cally segmented using a fixed threshold at a value slightly higher 
than the background to remove the contribution of noisy pixels. 
The average OPD was then measured within the segmented cells. 
Subsequently, the value of the four images taken per well was aver-
aged and used as the quantified value for adipocytic differentia-
tion. To count cell numbers or to quantify dead cells with DHM 
images, a segmentation tool for CellProfiler software (25) was 
used (Ridler Calvard’s algorithm). Cells were categorized to either 
“undifferentiated,” “adipocytic,” “dead,” or “errors” within the 
machine learning-based CellProfiler Classifier. The cells were sub-
sequently counted automatically, using either the Random Forest 
or k-Neighbors classification algorithms, with cells at the borders 
of the images excluded from the analysis.
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Fig. 1.  DHM is noninvasive and can be used to assess different features in lipid droplet accumulating cells. A: Schematic representation of 
DHM image acquisition. An infrared laser beam passes through the sample, while a reference beam passes in parallel without crossing the 
sample. B: Image reconstruction and analysis. The superimposition of both waves creates a hologram containing the phase shift information, 
which can then be mathematically reconstructed into a single-plane image. C: Information contained within the hologram. In addition to 
the phase shift information, DHM records the intensity absorption D: Superimposition of fluorescence lipid staining with DHM image. On 
the left are a digital phase contrast image (nonquantitative) and LipidTox Deep Red fluorescence images. On the right is the superimposi-
tion of LipidTox Deep Red signal with DHM signal. E: Signal intensity histogram of the cross-section seen as a horizontal red line passing 
through a lipid droplet-accumulating cell on the DHM image in D. F: CellProfiler software image analysis detects single cells, represented by 
their red outlines. Cells touching the borders are excluded. G: Cell counting using the aforementioned CellProfiler plugin. Increasing num-
bers of cells were seeded into a 384-well plate and counted from DHM images acquired 24 h after plating. H: Correlation of detection of OP9 
dead cells exposed to various toxic compounds from DHM images as compared with fluorescence (Fluo) images from Et-HD and Hoechst 
33342 stains. Dead cells were defined in the CellProfiler plugin as small and rounded with a high phase shift signal. Error bars are SD. Scale 
bar = 100 m.
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Fluorescence images were processed using the CellProfiler 
image analysis software. Uneven illumination gradients were 
corrected using the CorrectIllumination modules through a Gaussian 
blur. For LipidTox Deep Red signal quantification, the intensity 
was measured in a radius of 20 m around each Hoechst-stained 
nucleus. For Nile Red signal quantification, a mask of the cyto-
plasm was first created using the faint membrane staining of Nile 
Red. The Nile Red fluorescence intensity of the lipid droplets was 
then measured within this mask, and the median of all cells was 
calculated for each image. For both Nile Red and LipidTox stains, 
the median fluorescence intensity was quantified within the 
masks, and the four pictures taken per well were then averaged. 
For Et-HD signal quantification, an automatic threshold was used 
to segment the cells, and a fixed threshold was used to set the 
separation between positive and negative cells. The ratios of 
Et-HD positive cells within all four images were calculated and 
averaged for each well.
FACS
OP9 cells were plated in precoated 6-well plates at a density of 
20.000 cells per cm2 and induced to adipocytic differentiation for 
6 days. Prior to flow cytometric sorting, cells were stained with 
LipidTox Deep Red and propidium iodide (catalog no. 81845, 
Sigma-Aldrich) for 30 min, washed with PBS, and subsequently 
detached by incubating for 5 min in 0.05% trypsin-EDTA (Gibco, 
catalog no. 25300) at 37°C. The OP9 cells were then gently resus-
pended in PBS and sorted using the FACSAria Fusion Cell Sorter 
(BD Biosciences). They were collected into Eppendorf tubes, 
filtered using a 150 µm mesh, and subsequently plated into black 
wall 384-well plates at a density of around 4,000 cells per well. 
The settings for the side scatters (SSCs) and the forward scatters 
were based on the signal of noninduced OP9 cells as previously 
described (10).
RT-PCR
OP9 cells were plated in precoated 24-well plates at a density of 
20.000 cells per cm2 and induced toward adipocytic differentia-
tion for 6 days as described above. RNA was extracted using ZR 
RNA Microprep (catalog no. R1060, Zymo) following the manu-
facturer’s instructions. A DNase I digestion step was included. 
cDNA was synthesized using the SuperScript VILO cDNA synthe-
sis kit (catalog no. 11754-050, Life Technologies) following the 
manufacturer’s instructions. Quantitative real-time PCR was per-
formed on QuantStudio 6 (Life Technologies) using the following 
primer pairs: pparg: forward (Fw): 5′-ACCACTCGCATTCCTTT-
GAC; reverse (Rv): 5′-TGGGTCAGCTCTTGTGAATG; c/ebpa: Fw: 
5′-GTTAGCCATGTGGTAGGAGACA′; Rv: 5′-CCCAGCCGTTAGT-
GAAGAGT; glut4: Fw: 5′-GGCTTCTTCATCTTCACCTTC; Rv: 
5′-TGGGTTTCACCTCCTGCTCT; adipoq: Fw: 5′-TGTTCCTCT-
TAATCCTGCCCA; Rv: 5′-CCAACCTGCACAAGTTCCCTT; actb: 
Fw: 5′-CTAAGGCCAACCGTGAAAAGAT; Rv: 5′-CACAGCCTGGA-
TGGCTACGT; and hprt1: Fw: 5′-GCAGTACAGCCCCAAAATGG; 
Rv: 5′-AACAAAGTCTGGCCTGTATCCAA.
The geometric mean of both housekeeping genes (actb and 
hprt1) was used as reference to calculate the fold expression of 
each gene relative to the samples of noninduced OP9 cells 1 day 
after plating.
Triglyceride content
OP9 cells were plated in precoated 24-well plates at a density of 
20.000 cells per cm2 and induced to adipocytic differentiation for 
6 days. The cells were washed once with PBS and homogenized in 
300 l of 10% Triton X (catalog no. M143-1L, VWR). Triglycer-
ides (TGs) were solubilized by heating to 80°C in a water bath, 
cooling down to room temperature, and repeating, before storing 
at 80°C. After thawing, 25 l of each sample was taken for the 
biochemical assay using Triglyceride Quantification Colorimet-
ric/Fluorometric Kit (catalog no. K622-100, BioVision) following 
the manufacturer’s instructions in a 96-well black-walled plate. 
After 1 h reaction, the plate was read on an Infinite F5000 Spec-
trophotometer (Tecan, Switzerland) using the excitation/emis-
sion = 535/590 nm filter set for the fluorometric assay. The 
background signal was subtracted from all samples, and the TG 
concentration was estimated using the linear standard curve, 
which was not forced to intercept the y axis at y = 0.
Protein content
The protein content was quantified in parallel using the same 
samples that were solubilized in 10% Triton X for the TG content 
measurements. Twenty-five l of each sample was taken and mea-
sured using the Pierce BSA Protein Assay Kit (catalog no. 23227, 
Thermo Scientific) following the manufacturer’s instructions. 
After 30 min reaction, the absorbance was read on the spectro-
photometer using the 560 nm filter. The protein concentration 
was estimated using the linear standard curve, which was not 
forced to intercept the y axis at y = 0.
RESULTS
DHM imaging is noninvasive and can be used to assess 
different features in lipid droplet accumulating cells
In this study, we show how the ability of DHM to detect 
morphology and refractive index in a nonperturbing man-
ner makes this technique ideal to quantify lipid droplets in 
differentiating adipocytes.
We used the murine bone marrow-derived OP9 stromal 
cells (19). OP9 cells have been characterized as a useful 
model to study adipocytic differentiation thanks to their 
rapid rate of lipid droplet accumulation (20), even at high 
confluency or over long culture periods. When observing 
the signal intensity histogram of the cross-section of differ-
entiating OP9 cells, both the cytoplasmic signal and the 
highly refractive lipid droplets are clearly distinguishable 
from the background noise (Fig. 1E). This signal can also 
be used to assess different features of the cells including 
cell size, morphology, and confluence. Using a machine 
learning-based CellProfiler Classifier, we were able to cate-
gorize cells and assign them to “undifferentiated,” “adipo-
cytic,” or “dead” phenotypes. Undifferentiated cells were 
defined as large and with low OPD signal, adipocytic as 
large with high OPD signal, and dead cells as small and 
round with a high OPD signal. We plated OP9 cells at dif-
ferent concentrations, imaged them after 24 h, and 
counted individual cells (result of the CellProfiler segmen-
tation in Fig. 1F). As expected, a higher proportion of cells 
were detected in wells, which were initially seeded at a 
higher concentration (Fig. 1G). The exponentiality of the 
curve may represent the proliferation kinetics of cells; a 
higher initial cell number will predict a greater increase in 
cell numbers after 24 h. To assess the capacity of our work-
flow to detect dead cells, we first incubated OP9 cells with 
different known toxic compounds and acquired DHM im-
ages. The cells were then stained with Et-HD and Hoechst 
33342 (for dead cells and total cells, respectively) and imaged 
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using the InCell Analyzer 2000 (GE Healthcare). We plot-
ted each well and compared the fraction of Et-HD-positive 
cells from the fluorescence images with the fraction of 
dead rounded cells detected in DHM images. This correla-
tion is linear with R2 = 0.85, P < 0.0001 (Fig. 1H). The vari-
ability is increased with a higher proportion of dead cells, 
Fig. 2. Six-day time lapse of OP9 cells induced to differentiate toward adipocytes: Comparison of DHM and fluorescence microscopy. A: 
DHM images from day 1 to 6 postplating and induction. Top, 10×; bottom, 20×. B: Fluorescence images taken from day 1 to 6 postplating 
and induction. Blue is Hoechst 33342, and red is either LipidTox Deep Red (top) or Nile Red (bottom). C: OPD values of OP9 cells induced 
to differentiate (red) versus noninduced OP9 cells (blue). D, E: LipidTox Deep Red and Nile Red median signal intensities in both induced 
and noninduced OP9 cells. Note the error during the Nile Red staining procedure on day 4 postinduction of adipocytic differentiation. R2 = 
0.6 for OPD vs. LipidTox Deep Red and R2 = 0.54 for OPD vs. Nile Red. Error bars are SD. Scale bars = 100 m.
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which may be due to dead cells detaching from the bottom, 
characterized by a shift toward the right of the correlation 
curve.
DHM can be used to assess adipocytic differentiation
To assess the capacity of DHM imaging to recapitulate 
the quantification of lipid droplets, we compared it to clas-
sic imaging of stained neutral lipids. Specifically, we com-
pared the OPD signal with the fluorescence signal of both 
LipidTox Deep Red and Nile Red along a 6 day adipocytic 
differentiation period (Fig. 2). Due to the preadipocytic 
nature of OP9 cells, around 5% of the cells spontaneously 
differentiated toward adipocytes when left confluent over 6 
days (data not shown). The DHM images detected changes 
in differentiation after 2 days in culture (Z′ = 2.2, 0.06, 
0.23, 0.53, 0.65, and 0.6 for days 1–6, respectively; Fig. 2A, 
C), while it took at least 5 days to see any detectably stained 
lipid droplets by fluorescence images (Fig. 2B, D, E). Un-
fortunately, on the day 4 datapoint, the Nile Red staining 
did not yield sufficient cytoplasmic membrane staining, 
which, in turn, revealed a low overall intensity of lipid drop-
let quantification and thus revealed an outlier datapoint 
(Fig. 2E). This common artifact highlights the advantages 
of an alternative nonperturbing method to quantify lipid 
droplet accumulation. DHM reduces the number of vari-
ables introduced into each experiment, thus increasing the 
robustness and reproducibility of lipid droplet quantifica-
tion. The DHM-derived OPD signal correlated nonlinearly 
with both the LipidTox Deep Red and Nile Red Fluores-
cence signal with R2 = 0.6 and R2 = 0.54 respectively, P < 
0.0001 (data not shown).
In parallel, we quantified biochemically both the TG 
and the protein content over the course of the 6 day adi-
pocytic differentiation (Fig. 3A, B). As expected, the pro-
tein content stayed relatively constant, while the TG 
content increased almost 30-fold, reaching the plateau on 
day 4–5 postinduction. For comparison, the TG content of 
OP9 cells increased almost 5-fold over 6 days without in-
duction of differentiation. We also analyzed the transcrip-
tional profile using a set of known markers of adipocyte 
differentiation and function. We quantified two transcrip-
tion factors (pparg and c/ebpa) and two functional adipo-
cyte markers (adipoq and glut4). Owing to the preadipocytic 
nature of OP9 cells, all gene transcripts were upregulated 
after 6 days, even without induction of differentiation 
(Fig. 3C). Induction of adipocytic differentiation signifi-
cantly increased the transcription of all analyzed genes 
(pparg increased 2.5-fold; c/ebpa increased 10-fold; 
glut4 increased 20-fold; and adipoq increased 30-fold). 
All gene transcripts measured plateaued at 5 days of 
differentiation.
Furthermore, we stained OP9 cells with LipidTox Deep 
Red and sorted them based on their granularity as previ-
ously shown (10, 22) (Fig. 4A). Note that the dynamic 
range and resolution of cells exhibiting different levels of 
adipocytic differentiation was higher in the SSC in linearity 
Fig. 3. A: Total TG and protein content of OP9 cells 
during the 6 day adipocytic differentiation. Quantifi-
cation is based on the standard curve from the manu-
facturer’s control. B: Relative TG content over protein 
content during the 6 day differentiation. C: The tran-
scriptional profile of relevant genes involved in the 
adipocytic differentiation of OP9 cells. Values are nor-
malized to noninduced OP9 cells 1 day postplating 
and the geometric mean of two housekeeping genes: 
hprt1 and actb. Error bars are SD.
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than along the fluorescence axis in exponentiality. 
The cells were plated and underwent DHM imaging 24 h 
later (Fig. 4C). As expected, cells with a higher initial 
SSC signal also had a higher OPD signal. Of note, cells 
sorted from the A3 gate (representing the most mature 
adipocytes) exhibited less adherent behavior, explaining 
why the cell density was lower on their corresponding 
images. These mature A3 cells also appeared rounder, 
although their OPD signal was not significantly different 
(Fig. 4B).
DHM imaging is robust and high-throughput
Finally, we assessed the capacity of DHM imaging to 
identify modulators of adipocytic differentiation in a high-
throughput manner. We cultured OP9 cells with known 
enhancers (rosiglitazone, pioglitazone, and indometha-
cin) of adipocytic differentiation (Fig. 5A, right) as well as 
with known PPAR inhibitors (T0070907, GW9662, and 
BADGE; Fig. 5A, left) in a dose-responsive manner in a 384-
well plate. Inhibitors of adipocytic differentiation were 
plated in combination with the adipogenesis induction 
cocktail DMI to test the strength of their inhibitory ca-
pacities. The compounds were tested in 14 different 
concentrations ranging from 100 µM (Fig. 5A, top) to 4.6 
nM (Fig. 5A, bottom). As visualized from the images, 
PPAR inhibitors increasingly prevented adipocyte dif-
ferentiation at higher concentrations, while adipogenesis 
enhancers triggered adipocytic differentiation more effi-
ciently at higher concentrations. As shown in the high-
magnification insert, PPAR inhibitors are toxic at high 
concentrations (>10 µM), making the cells appear round 
with a high phase shift signal (Fig. 5A). T0070907 pre-
sented the most potent effect of the three tested inhibitors 
and could revert the OPD signal back to control levels be-
fore reaching toxic concentrations. Specifically, T0070907 
exhibited an IC50 = 1.49 µM; GW9662, IC50 = 4.49 µM; and 
BADGE, IC50 > 100 µM (Fig. 5B). Within the enhancers of 
adipocyte differentiation, rosiglitazone exhibited the most 
potent effect with an IC50 = 19.5 nM, while pioglitazone 
and indomethacine had IC50 values of 1.23 and 2.77 µM, 
respectively (Fig. 5C).
DISCUSSION
OP9 cells are bone marrow-derived MSCs/preadipocytes 
that can efficiently differentiate into adipocytes (19, 20, 
26). Their differentiation process can be studied from day 
2 and is characterized by the early expression of PPAR, 
C/EBP, C/EBP, and SREBP1 (20) transcription factors. 
PPAR is a master regulator of adipocytic differentiation. It 
translocates to the nucleus upon activation and drives 
adipocytic commitment, while preventing the cells from 
differentiating along the osteogenic lineage by directly in-
hibiting runx2 transcription (27). In addition, OP9 cells 
are nonclonal, allowing us to evaluate heterogeneity within 
differentiating cells.
Label-free and noninvasive imaging of in vitro differ-
entiating adipocytes is crucial to limit the adverse effects 
caused by staining, washing, and other liquid manipula-
tions used in fluorescence microscopy. In this study, we 
have shown that the quantitative phase images generated 
by holographic microscopy are able to provide a variety 
of information on cell morphology, including cell conflu-
ence, cell death, and lipid droplets, in a nonperturbing 
manner, thus reflecting true physiologically relevant 
Fig. 4. OPD signal of FACS-sorted OP9 cells induced 
to differentiate toward adipocytes during a time pe-
riod of 6 days. A: Flow cytometric gates were chosen 
along the SSC signal (representing different stages of 
lipid accumulation), sorted separately, and subse-
quently plated into a 384-well plate. B: Average OPD 
signal of sorted OP9 cells 24 h after plating. Images 
without cells were removed from analysis. C: Represen-
tative DHM images of sorted OP9 cells. Top, 10×; bot-
tom, 20×. Error bars are SD. Scale bars = 100 m.
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Fig. 5. DHM imaging can be used to identify inhibitors and enhancers of adipogenesis in a high-throughput manner. A: Snapshot of a 
384-well plate presenting a montage of DHM images of OP9 cells incubated with different PPAR antagonists and agonists at different 
concentrations (one image per well). On the left half of the plate, OP9 cells were induced to differentiate to adipocytes while incubated 
with different PPAR inhibitors (T0070907, GW9662, and BADGE). On the right half of the plate, OP9 cells were not induced with the 
standard differentiation cocktail, but incubated with different PPAR agonists (rosiglitazone, pioglitazone, and indomethacine). The small 
inset on the top shows dead cells B: Dose-response curves of different tested PPAR inhibitors. C: Dose-response curves of the differ-
ent tested PPAR agonists. Dashed lines represent baseline OPD values for induced (DMI) or noninduced (no DMI) OP9 cells. Error bars 
are SD.
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measurements. Using the freely available machine learn-
ing plugin for CellProfiler, we were able to categorize 
OP9 cells into “adipocytic,” “undifferentiated,” or “dead” 
phenotypes. The information given on cell confluence 
and categorization can also be envisioned to study hyper-
trophy versus hyperplasia behavior in differentiating adi-
pocytes. To quantify adipocytic differentiation in bulk, 
simply the OPD within the cytoplasmic areas provided an 
accurate quantification of lipid droplets. We correlated 
the OPD measurement to fluorescence microscopy: Et-
HD/Hoechst 33342 costaining for cell death and Lipid-
Tox Deep Red/Hoechst 33342 costaining for lipid 
droplets. Variations caused by liquid manipulations, illu-
mination irregularities, dependence on dye concentra-
tions, staining times, and bleaching are key issues in 
fluorescence microscopy and therefore strongly compro-
mise quantification accuracy and robustness. DHM 
proved to be more sensitive than fluorescence micros-
copy, allowing detection of differences in adipocyte dif-
ferentiation up to 3 days earlier. Another key feature of 
DHM is that multiple independent time points can be 
measured; the same cells were imaged in a time lapse 
without any of the compromises of fluorescence micros-
copy. In our study, we took four pictures per well on a 
384-well plate, which took roughly 10 min. The ability to 
digitally refocus on the cells postimaging speeds up the 
process of data collection and adds to the simplicity of 
the imaging procedure toward a higher throughput. We 
also compared DHM imaging with flow cytometry, an-
other validated strategy of adipogenesis quantification. 
In this case, DHM quantification also correlates with the 
flow cytometric measurement. However, within late-stage 
differentiating adipocytes, the increase in OPD signal 
does not seem to increase significantly, which may be due 
to floating cells not being measured at late differentia-
tion stages with DHM. Quantification of lipid droplets 
using flow cytometry is also limited by variabilities in cell 
collection, cell floating, and the fragility of terminally dif-
ferentiated adipocytes. We further tested the robustness 
of DHM to assess lipid droplet accumulation in differen-
tiating adipocytes by incubating OP9 cells with PPAR 
agonists and antagonists in a dose-responsive manner. 
We were able to calculate the IC50 for each of the tested 
compounds and showed that, with high doses of PPAR 
agonists, adipocytic differentiation can be pushed fur-
ther than with our standard differentiation cocktail. 
Taken together, our study shows that this novel, nonper-
turbing imaging method can be used to assess a variety of 
morphological features without the need of developing 
lengthy and tedious staining protocols. The DHM, be-
sides reducing costs in consumables, is therefore a pow-
erful tool envisioned for future drug screenings and 
mechanistic studies on adipocyte differentiation.
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